Literature DB >> 17928684

Assessment of prion inactivation by combined use of Bacillus-derived protease and SDS.

Miyako Yoshioka1, Yuichi Murayama, Takehiro Miwa, Katsuhiro Miura, Masuhiro Takata, Takashi Yokoyama, Koji Nishizawa, Shirou Mohri.   

Abstract

Prions, infectious agents causing transmissible spongiform encephalopathy, retain infectivity even after undergoing routine sterilization processes. We found that MSK103 protease, identified in our previous study, effectively reduces infectivity and the level of misfolded isoform of the prion protein in scrapie-infected brain homogenates in the presence of SDS. The treatment therefore can be applied to the decontamination of thermolabile instruments.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17928684     DOI: 10.1271/bbb.70257

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  4 in total

Review 1.  Lichens: unexpected anti-prion agents?

Authors:  Cynthia M Rodriguez; James P Bennett; Christopher J Johnson
Journal:  Prion       Date:  2012 Jan-Mar       Impact factor: 3.931

2.  Degradation of the disease-associated prion protein by a serine protease from lichens.

Authors:  Christopher J Johnson; James P Bennett; Steven M Biro; Juan Camilo Duque-Velasquez; Cynthia M Rodriguez; Richard A Bessen; Tonie E Rocke
Journal:  PLoS One       Date:  2011-05-11       Impact factor: 3.240

Review 3.  Distinct origins of dura mater graft-associated Creutzfeldt-Jakob disease: past and future problems.

Authors:  Atsushi Kobayashi; Yuichi Matsuura; Shirou Mohri; Tetsuyuki Kitamoto
Journal:  Acta Neuropathol Commun       Date:  2014-03-31       Impact factor: 7.801

4.  Subcritical Water Hydrolysis Effectively Reduces the In Vitro Seeding Activity of PrPSc but Fails to Inactivate the Infectivity of Bovine Spongiform Encephalopathy Prions.

Authors:  Yuichi Murayama; Miyako Yoshioka; Hiroyuki Okada; Eri Takata; Kentaro Masujin; Yoshifumi Iwamaru; Noriko Shimozaki; Tomoaki Yamamura; Takashi Yokoyama; Shirou Mohri; Yuji Tsutsumi
Journal:  PLoS One       Date:  2015-12-16       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.